AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 13, 2026

Becton Dickinson & Co BDX Stock Forecast

AI-powered price prediction and analysis for Becton Dickinson & Co · Total · absolute moveSwitch to Alpha

Follow
AI 90-Day Forecast ▼ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See BDX's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

BDX
Fundamentals

Key Statistics

Market Cap$51.04B
P/E Ratio54.2x
P/B Ratio2.09x
Div. Yield2.30%
EPS$3.08
ROE3.9%
Net Margin4.7%
Revenue$20.07B
Current Ratio0.87x
D/E Ratio1.08x
Company

About Becton Dickinson & Co

Becton Dickinson & Co (BDX) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.

Industrial Applications and Services Surgical & Medical Instruments & Apparatus NYSE Large Cap
News

Latest News

  • Loading...

Where BDX sits on the market map

Industrial Applications and Services · Surgical & Medical Instruments & Apparatus
Explore the map →
Industry Peers

Surgical & Medical Instruments & Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
BDX Becton Dickinson & Co ▼ $51.04B 54.2x
SYK Stryker Corp ▼ $108.38B 29.1x
MMM 3m Co ▼ $83.94B 28.0x
BSX Boston Scientific Corp ▼ $62.77B 17.1x
MDLN Medline Inc. ▼ $46.94B –
RMD Resmed Inc ▼ $33.91B 22.3x
DXCM Dexcom Inc ▶ $32.42B 32.4x
WST West Pharmaceutical Services Inc ▼ $26.17B 46.3x
SOLV Solventum Corp ▼ $14.69B 10.2x
BAX Baxter International Inc ▶ $12.87B –
PEN Penumbra Inc ▼ $12.61B 78.5x
GMED Globus Medical Inc ▼ $10.25B 19.1x
GKOS Glaukos Corp ▲ $9.76B –
PODD Insulet Corp ▼ $9.58B 25.5x
STVN Stevanato Group S.P.A. ▲ $5.83B –
HAE Haemonetics Corp ▼ $5.54B 57.5x
TFX Teleflex Inc ▼ $5.27B –
MMSI Merit Medical Systems Inc ▼ $5.26B 36.2x
MMED Minimed Group, Inc. ▶ $5.18B –
HTFL Heartflow, Inc. ▲ $4.38B –
ICUI Icu Medical Inc/De ▼ $4.08B –
IRTC Irhythm Holdings, Inc. ▼ $3.55B –
PLSE Pulse Biosciences, Inc. ▲ $3.46B –
ATRC Atricure, Inc. ▶ $2.89B –
UFPT Ufp Technologies Inc ▶ $2.28B 31.5x
INSP Inspire Medical Systems, Inc. ▶ $1.99B 14.7x
LMAT Lemaitre Vascular Inc ▶ $1.86B 28.4x
ATEC Alphatec Holdings, Inc. ▲ $1.67B –
NVCR Novocure Ltd ▲ $1.67B –
KMTS Kestra Medical Technologies, Ltd. ▲ $1.61B –
DRTS Alpha Tau Medical Ltd. ▲ $1.26B –
TNDM Tandem Diabetes Care Inc ▶ $1.16B –
IRMD Iradimed Corp ▲ $1.15B 49.7x
BVS Bioventus Inc. ▶ $1.14B 20.9x
PRCT Procept Biorobotics Corp ▲ $1.09B –
IART Integra Lifesciences Holdings Corp ▶ $1.08B –
AORT Artivion, Inc. ▶ $1.04B –
SIBN Si-Bone, Inc. ▶ $882M –
SGP Spyglass Pharma, Inc. ▲ $800M –
BBNX Beta Bionics, Inc. ▲ $796M –
MDXG Mimedx Group, Inc. ▲ $684M –
KIDS Orthopediatrics Corp ▶ $573M –
SSII Ss Innovations International, Inc. ▶ $511M –
TCMD Tactile Systems Technology Inc ▶ $505M 20.3x
BWAY Brainsway Ltd. ▲ $467M –
SGHT Sight Sciences, Inc. ▲ $462M –
CERS Cerus Corp ▲ $455M –
ANGO Angiodynamics Inc ▲ $451M –
NPCE Neuropace Inc ▲ $435M –
RCEL Avita Medical, Inc. ▲ $413M –
CARL Carlsmed, Inc. ▲ $395M –
OFIX Orthofix Medical Inc. ▼ $377M –
EMBC Embecta Corp. ▶ $351M 4.0x
OBIO Orchestra Biomed Holdings, Inc. ▲ $344M –
CLPT Clearpoint Neuro, Inc. ▲ $299M –
MOBI Mobia Medical, Inc. ▲ $283M –
ANIK Anika Therapeutics, Inc. ▲ $275M –
TMCI Treace Medical Concepts, Inc. ▲ $267M –
OSUR Orasure Technologies Inc ▲ $263M –
PROF Profound Medical Corp. ▲ $256M –
FAQ

FAQ

Is Becton Dickinson & Co a good stock to buy?

Our AI analyzes Becton Dickinson & Co daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Becton Dickinson & Co predictions?

A per-ticker accuracy statistic for BDX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Becton Dickinson & Co forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Becton Dickinson & Co? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.